Cargando…
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007781/ http://dx.doi.org/10.1186/1479-5876-8-S1-P37 |
| _version_ | 1782194425777094656 |
|---|---|
| author | Fossati, G Nesbitt, A |
| author_facet | Fossati, G Nesbitt, A |
| author_sort | Fossati, G |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3007781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30077812010-12-23 Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays Fossati, G Nesbitt, A J Transl Med Poster Presentation BioMed Central 2010-11-25 /pmc/articles/PMC3007781/ http://dx.doi.org/10.1186/1479-5876-8-S1-P37 Text en Copyright ©2010 Nesbitt and Fossati; licensee BioMed Central Ltd. |
| spellingShingle | Poster Presentation Fossati, G Nesbitt, A Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title | Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_full | Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_fullStr | Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_full_unstemmed | Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_short | Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_sort | certolizumab pegol has a different profile from other anti-tnfs, including golimumab, in a variety of in vitro assays |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007781/ http://dx.doi.org/10.1186/1479-5876-8-S1-P37 |
| work_keys_str_mv | AT fossatig certolizumabpegolhasadifferentprofilefromotherantitnfsincludinggolimumabinavarietyofinvitroassays AT nesbitta certolizumabpegolhasadifferentprofilefromotherantitnfsincludinggolimumabinavarietyofinvitroassays |